INS and Hypoglycemia: Oral casNP/insulin/C10 (50 IU/kg) exhibited a bloodsugar-lowering efficacy comparable to subcutaneously injected InsulinAspart (5 IU/kg), while extending the duration of action by approximately6 h and preventing hypoglycemia in fasted mice.